The impact of nanomaterials in immune system by 理쒖씤�솉
IMMUNE NETWORK http://www.ksimm.or.kr Volume 10 Number 3 June 2010
DOI 10.4110/in.2010.10.3.85
pISSN 1598-2629    eISSN 2092-6685
85
REVIEW ARTICLE
Received on April 9, 2010. Revised on April 20. Accepted on April 23, 2010.
CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial 
License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribu-
tion, and reproduction in any medium, provided the original work is properly cited.
*Corresponding Author. Tel: 82-2-2228-1821; Fax: 82-2-392-7088; E-mail: inhong@yuhs.ac
Keywords: Nanomaterials, Immune response, Cytokines, Immunological diseases
The Impact of Nanomaterials in Immune System
Jiyoung Jang, Dae-Hyoun Lim and In-Hong Choi*
Department of Microbiology, College of Medicine and Nanomedical National Core Research Center, Yonsei University, Seoul, Korea 
As a nanotechnology has been actively applied to the overall 
areas of scientific fields, it is necessary to understand the 
characteristic features, physical behaviors and the potential 
effects of exposure to nanomaterials and their toxicity. In this 
article we review the immunological influences induced by 
several nanomaterials and emphasize establishment of the 
animal models to estimate the impact of these nanomaterials 
on development of immunological diseases. 
[Immune Network 2010;10(3):85-91]
INTRODUCTION
A nanotechnology which has appeared since the mid-twenties 
century has provided the methods by which the limitations 
in the industrial application of each scientific technology 
could be overcome. It has also brought another revolutionary 
change to the overall areas in the scientific technology and 
the related industries. A nanotechnology has become a basis 
of the integrated development of scientific technology which 
has independently been developed. It has also been actively 
applied to the overall areas of scientific fields. The character-
istics of nanomaterials are subject to their surface property, 
according to which the desirable physical property can be 
given deliberately to them. 
  As described here, products manufactured using nano-
materials are characterized to overcome the areas which can-
not be resolved with the previous technology. It can therefore 
be stated that they have a higher degree of applicability. 
Synchronously, there is an increasing concern that they would 
be new hazardous factors for both humans and nature (1). 
In identifying and then clarifying risks due to exposure to 
nanomaterials, it is extremely important to clarify the phys-
icochemical property and physical behavior of nanomaterials 
and to understand the biological and physiological actions of 
them in an in vivo setting (2). Based on this, a systematic 
approach should be made to examine the possible detri-
mental effects on the production, environment and health. In 
general, methods for assessing the detrimental effects of con-
ventional types of chemicals are divided into the definition 
of detrimentalness, the assessment of dose-response, that of 
exposure and that of detrimental characteristics. These meth-
ods can also be applied to nanomaterials. In nanomaterials, 
however, as their surface area is increased, their responsive-
ness and toxicity to viable tissues are also increased (3). It 
is of prime importance to clarify new physicochemical prop-
erty and to evaluate the resulting toxicity of them. 
Accordingly in the assessment of detrimentalness of nano-
materials, it is necessary to understand the characteristic fea-
tures, physical behaviors, the potential effects of exposure to 
nanomaterials and their toxicity (4). 
IMMUNOLOGICAL EFFECTS OF NANOMATERIALS
Nanomaterials have a structure that the size of one of three 
surfaces is 1∼100 nm according to the definition made by 
ISO/TC 229. As described here, based on a smaller size of 
＜100 nm, nanomaterials have physicochemical properties 
which are greatly different from general types of other 
substances. Due to a higher degree of surface reactivity and 
the cell membrane permeability, an in vivo influx of nano-
materials produces the stress on a cellular level.
  Until the year of 2006, 69% of total manuscripts published 
on a peer-reviewed journal are related to the toxicity and the 
remaining 31% are related to the exposure. In particular, 
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Table I. Immunotoxicity of carbon-based nanomaterials
Nanomaterials 　　　Summary Reference no.
Carbon black (<100 nm) Induction of MCP-1, CCL2, IL-6, C-reactive protein and 25
  exaggeration of arthrosclerosis in animals
Carbon black (14 nm) Induction of slight expression of CD80 and MHC class II 26
  and significant expression of CD86 and DEC205 in endothelial cells
Single-walled carbon nanotubes Persistence of SWNT for several months in kidney and liver 27
  (PEG coating 1∼5 nm in diameter,   without obvious toxicity
  50∼200 nm in length)
Single-walled carbon nanotubes Biodegradation of single-walled carbon nanotubes by hypochlorite and 28
  (1∼4 nm in diameter)   ROS mediated byf human neutrophil myeloperoxidase 
Single-walled carbon nanotubes Induction of ROS, inflammatory cytokines and expression of apoptosis 29
  (1∼2 nm in diameter 20 nm-several   related genesin macrophages
  μm in length)
Single-walled carbon nanotubes Inhibition of production of IL-8, 6, TNF-α and  MCP-1 in A549 cells 30
  (800 nm length)
Multi-walled carbon nanotubes Induction of fibrosis in asthma animal model and suggestion of the role 31
  (10∼30 nm in diameter   of  TGF-β and PDGF
  30∼50 nm in length)
Multi-walled carbon nanotubes Induction of ROS, inflammatory cytokines and activation of NF-kB 32
  (20∼40 nm in diameter,   in A549 or BEAS-2B cells
  5∼30μm in length)
C60 fullerene (0.7 nm in diameter) No toxicity in animal lung 33
since 2008, research articles about the toxicity have been 
abruptly increased. These articles have reported the pulmo-
nary toxicity, neurotoxicity and the permeability to blood- 
brain-barrier. Besides, peer-reviewed articles about the im-
munotoxicity have also been increasingly published.
  Nanomaterials are crystalline, fine particles with a large sur-
face area, and they have a higher degree of surface charge 
and proton exchangeability. Besides, it is also expected that 
they might have a positive effect on the environment because 
they facilitate the synthesis and transportation of contaminants 
in the environment. In addition, the potential problems of 
nanomaterials are not limited to the environmental pollution. 
By various routes such as an inhalation, they are absorbed 
into the body and then induce the biological toxicity (5,6). 
This makes nanomaterials further interesting. The possible 
routs by which nanomaterials migrate in the human body in-
clude the following:
  1) Endocytosis: Nanomaterials enter the cells when they are 
surrounded by the cell membrane without passing it.
  2) Cell membrane penetration occurring with the action of 
hydrophobic particles.
  3) Transportation of nanoparticles with a size of ＜5 nm 
across the cell membrane channel.
  As described here, it has been proposed that the con-
tactable nanoparticles might stimulate the immune system in 
the body. By contrast, recent studies have been conducted 
to examine industrial nanoparticles. Industrial nanoparticles 
are mainly contacted in a working place by daily commodities 
or pharmaceutical products in customers. The total amount 
of exposure may be relatively lower or the actual one occur-
ring in the local tissue might be relatively higher. 
Nanoparticles produce oxygen radicals (7,8). Besides, the mi-
tochondrial perturbation and apoptosis (9) are induced, 
which are followed by the cytotoxicity. With the reactions 
with body proteins and other biological substances, various 
types of hazardous reactions might occur.
  One of the advantages of nanoparticles, a biological perme-
ability makes an intracellular and intranuclear influx of nano-
materials possible. Based on these findings, it has therefore 
been postulated that the oxidative stress and inflammatory re-
sponses induce the occurrence of immunotoxicity directly or 
indirectly. It is therefore imperative that the technology for 
assessing the exposure be established to examine the phys-
icochemical properties of nanomaterials and to clarify the re-
lated immunotoxic mechanisms.
  Peer-reviewed articles about the toxicity of nanomaterials 
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Table II. Immunotoxicity of metal-based nanomaterials
Nanomaterials Summary Reference no.
TiO2 (0.02∼0.03μm) Induction of ROS but not TNF-α in respiratory epithelial cells 34
TiO2 (4∼6 nm, rutile) Induction of monocytes and lung inflammation, cardiac edema and 35
  systemic inflammation but decrease of platelets
TiO2 (20 nm) Engulfment of TiO2 by alveolar macrophages within24 hours in animal treatment 36
TiO2 (15, 50, 100 nm) Induction of histamine release without allergens 37
TiO2 (<100 nm) Induction of apoptosis and necrosis in macrophage cells 38
Gold (13 nm) Induction of apoptosis and acute inflammation in liver and localization of 39
  nanoparticles in Kupffer cells of liver and macrophages in spleen
Gold (2, 40 nm) Internalization by both microglial cells and primary hippocampal neurons and 40
  toll-like receptor 2 up-regulation in the olfactory bulb;
  up-regulation of TLR-2, IL-1α, GM-CSF and nitric oxide in microglia
Gold (0.8∼15 nm) No changes in mRNA induction of pro-inflammatory (TNF-α, IL-8, iNOS) and 41
  oxidative stress markers (HO-1, SOD) as well as IL-1, IL-2, IL-4, IL-6, IL-8, IL-10,
  GM-CSF, TNF-α, INF-γ
Fe2O3 Induction of pro-inflammatory cytokines (IL-1, TNF-α, IL-6), TH0 cytokine (IL-2), 42
  TH1 type cytokine (IL-12), TH2 type cytokines (IL-4, IL-5), TGF-α and IgE
Fe2O3 Decrease in cell viability associated with significant increases in lactate 43
  dehydrogenase activity, IL-1α and ferritin expression
Zinc oxide (11 nm), Induction of ROS, apoptosis and inflammation by ZnO but  inhibition of ROS by CeO2 44
  cerium oxide (8 nm)
Table III. Immunotoxicity related of silica or polystyrene-based nanomaterials
Nanomaterials Summary Reference no.
Silicon No acute irritation in HaCaT keratinocytes, a human skin equivalent 45
  model (HSEM), and in vivo mouse model 
Silica particles (12 nm) Increased blood level of IL-1β and TNF-α in blood, and increased release of 46 
  nitric oxide released from peritoneal macrophages; increased.
  mRNA expressions of IL-1, IL-6, TNF-α, iNOS, and COX-2 
Silica (70, 300, 1,000 nm) Induction of liver damage and inflammatory cytokines by 70 nm particles, 47
  but not 300 or 1,000 nm particles
Polystyrene (60 nm) Highly toxic to BEAS-2B cells, human microvascular endothelial cells, 48
    hepatoma cells, microvascular endothelial cells and macrophages 
Polystyrene nanoparticles Uptake of polystyrene nanoparticles by dendritic cells and migration of dendritic 49
  (20, 500, 1,000 nm)   cells to lymph nodes
Latex nanomaterial Induction of fibrinogen, MCP-1 by 25 or 50 nm particles, but not by 50
  (25, 50, 100 nm)   100 nm particles
have been summarized based on the chemical constituents. 
Based on the classification system into carbon nanomaterials, 
metals, metal-oxide nanomaterials and other silicas, a review 
of the above peer-reviewed journals was made. Results were 
represented in Tables I, II and III. For example, of carbon 
nanomaterials, carbon black induces the immune responses. 
In particular, multi-walled carbon nanotubes (MWCNT) rather 
than single-walled carbon nanotubes (SWCNT) induce the ac-
tivation of immune responses to a greater extent (Table I). 
Of metals and metal oxides, iron oxide nanoparticles strongly 
induce the immune responses. Besides, gold nanoparticles in-
duce a moderate degree of the immune responses. Further-
more, TiO2 induces a lower degree of the immune responses 
(Table II). In addition, it has also been reported that such 
substances as silica, polystyrene and latex nanomaterials have 
an immunotoxicity (Table III).
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Figure 1. Potential contribution of nanomaterials on asthma patho-
physiology.
THE NECESSITY FOR CONDUCTING STUDIES 
ABOUT THE RELATEDNESS TO DISEASE THROUGH 
AN ANIMAL EXPERIMENTAL MODEL OF 
PULMONARY DISEASES IN AN IN VIVO SETTING
Relatedness of nanomaterials to diseases can be presumed 
based on studies about the particulate matter (PM) associated 
with air pollution and the diseases (10-12). A long-term ex-
posure to particulate matter (PM) increases the incidence of 
complications associated with pulmonary (13,14) and car-
diovascular diseases (15) and the resulting mortality. The oc-
currence of malignant mesothelioma due to an inhalation of 
asbestos fiber (16,17), which has become a socially issue in 
recent years, well illustrates the hazardousness of micro-
particles. Particulate matters (PM10) of ＜10μm in size are 
associated with respiratory diseases such as asthma, chronic 
obstructive pulmonary disease (COPD), acute/chronic bron-
chitis and lower respiratory tract diseases and cardiovascular 
diseases such as myocardial infarction, arrhythmias and 
arteriosclerosis. Besides, particulate matters (PM2.5) of ＜2.5 
μm in size have a poorer effect on the respiratory system 
and cardiovascular one as compared with PM10 and they also 
raise the mortality. An analysis was performed for the correla-
tion between the concentration of PM2.5 and the mortality 
in the USA, according to which 100,000 people are found to 
die directly or indirectly due to PM2.5 every year. 
  The number of particulate matters in the atmosphere has 
been reported to be associated with the occurrence of respira-
tory diseases. Since then, it has been proposed that nano-
particles inhaled through a mathematical model of the ex-
pansion of human lungs might be deposited in an area rang-
ing from the trachea to terminal bronchioles. The surface area 
of particles rather the amount of particles are associated with 
the occurrence of inflammatory responses. At the present, no 
studies have provided the possibility that carbon nanotubes, 
nano-fibers and nano-wire products might induce the detri-
mentalness to such an equivalent extent to asbestos. 
Nevertheless, to rule out this possibility, it is imperative that 
the safety following a long-term exposure to above materials 
be audited. An experimental animal model of a long-term ex-
posure would therefore be mandatory.
  Nanoparticles contained in particulate matter are known as 
a strong inducer of oxidative stress in macrophages and epi-
thelial cells lining the airway tract. They increase the activity 
such molecules as MAP kinase, NF-κB and AP-1 and also 
promotes the synthesis of oxygen radicals (18,19). This phe-
nomenon is explained as one of the key pathophysiologic 
mechanisms by which COPD occurs, one of the representa-
tive chronic inflammatory respiratory tract diseases. It has 
been hypothesized that COPD might be a type of dust-in-
duced diseases. In this regard, the use of particulate matters 
and biomass fuel which has recently been of increasing inter-
est has been considered as a pathogenesis of COPD. 
Nanoparticles contained in the atmosphere have a possibility 
for aggravating the respiratory diseases. 
  In a murine model of asthma, one of the respiratory dis-
eases, particulate matter of 0.2∼10μm in size was ex-
perimentally administered. According to this experiment, as 
the size of particles was relatively smaller, the deposition to 
the lower respiratory tracts was increased. Following the ad-
ministration of microparticles into the airway tract in the 
above experimental model, the concentration of protein in 
the bronchoalveolar lavage is increased (20) and this is also 
accompanied by the increased occurrence of eosinophilic and 
neutrophilic inflammations occurring in the airway tract and 
the elevated levels of TH2 cytokines (IL-4, IL-5 and eotaxin) 
(21,22) as well as TH1 cytokines (IFN-γ, IL-6 and TNF-α) 
(23). Besides, following an intranasal administration of oil 
flash ash, a key substance for pathological phenomena due 
to particulate matters in a murine model of asthma, the occur-
rence of respiratory hypersensitivity and eosinophilic in-
flammation was further increased (24).
  In regard to the effects of nanoparticles on the asthma, a 
murine model of albumin-induced asthma has shown that the 
inflammatory responses and the production of immunoglo-
bluins were increased by nanoparticles in the respiratory tract 
(Fig. 1). These inflammatory phenomena are explained by 
the expression of IL-5 and eotaxin which was induced in the 
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early stage of inflammation. Subsequently, with the induced 
expression of such cytokines as IL-13, RANTES and MCP-1, 
the degree of inflammation was further increased. Moreover, 
based on the reports that TiO2 which has frequently been 
used for cosmetic products aggravates the atopic dermatitis, 
it has been proposed that nanoparticles might aggravate the 
immune diseases.
  In conclusion, with the development of nanotechnology, a 
great deal of nanoproducts and the related materials have 
been produced. Due to a lack of the clarification of the po-
tential hazard of technical development, however, demand 
and supply of the products have not been activated up to 
present. At the present, therefore, if guidelines or landmarks 
should be provided for safety assessment or data about the 
safety range including the immune toxicity of nanomaterials, 
this would greatly contribute to the activation of nanoin-
dustry.
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